- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02962505
Continuous Regional Analysis Device for Neonate Lung (CRADL)
March 19, 2019 updated by: Inez Frerichs, University Hospital Schleswig-Holstein
The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement.
The study design is purely observational.
Study Overview
Status
Completed
Detailed Description
EIT data will be recorded during 72 hours of routine clinical treatment.
To prevent any decisions based on EIT information, the clinicians will be blinded to the EIT findings during the study period.
Data on clinical interventions and clinical findings will be recorded using a specially adapted graphical user interface on the EIT device in combination with a paper-based case report form (CRF). EIT data analysis will be performed off-line.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nicosia, Cyprus
- Archbishop Makarios III Hospital
-
-
-
-
-
Oulu, Finland
- Oulu University Hospital
-
-
-
-
-
Amsterdam, Netherlands
- VU University Medical Center
-
Amsterdam, Netherlands
- Academic Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 7 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This study specifically focuses on the EIT monitoring of preterm and term neonates, small infants and children up to the age of 7 years treated in NICU and PICU as this is the population where the need for regional lung function monitoring tools is most urgently needed to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, alveolar recruitment, etc.) and prevent/minimize the occurrence of acute (pneumothorax, endotracheal tube misplacement) and chronic (chronic lung disease or bronchopulmonary dysplasia) adverse effects.
Description
Inclusion Criteria:
- Written, informed consent of both parents or legal representative
- Admission in the NICU or PICU
Patients with or at high risk of developing respiratory failure needing respiratory support.
o i.e. (oxygen need (FiO2>25%) AND noninvasive or invasive respiratory support) AND/OR repeated apnea with desaturations
- Age from birth to 7 years o Initial focus will be on neonates up to 6 kg and 12 months age. Infants of higher weight up to 7 years age will be included as EIT belts for this age group become available.
Exclusion Criteria:
- Post menstrual age less than 25 weeks
- Body weight < 600 g
- Electrically active implants
- Thorax skin lesions
- Prior participation for the same diagnosis of lung disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in aggregate measure of ventilation homogeneity (coefficient of variation and global inhomogeneity index of regional tidal volume) by > 10% compared with baseline
Time Frame: 72 hours
|
72 hours
|
|
Change in right-to-left and/or anteroposterior ventilation distribution by >10% compared with baseline
Time Frame: 72 hours
|
72 hours
|
|
Time and duration of right-to-left or left-to-right ventilation ratio >2:1
Time Frame: 72 hours
|
72 hours
|
|
Percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of < 700 Ohm
Time Frame: 72 hours
|
Skin contact impedance will be monitored continuously by the EIT device.
If more than 6 sensors exhibit skin contact impedance > 700 Ohm, the examination is no longer suitable for analyzing.
To assess the percentage of EIT measurements suitable for analyzing, we will calculate the percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of less than 700 Ohm.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Relationship between time of onset/end of non-invasive respiratory support and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of intubation/extubation and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of suctioning and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time and type of posture change and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of surfactant administration and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of clinically indicated radiological examination and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of recruitment manoeuvre and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of confirmed pneumothorax and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between time of confirmed endotracheal tube malposition and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between primary cause of respiratory failure and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between fraction of inspired oxygen over time and EIT findings
Time Frame: 72 hours
|
72 hours
|
Relationship between saturation of peripheral oxygen over time and EIT findings
Time Frame: 72 hours
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Inez Frerichs, MD, University Medical Center SH, Kiel , Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2016
Primary Completion (Actual)
March 3, 2019
Study Completion (Actual)
March 3, 2019
Study Registration Dates
First Submitted
November 3, 2016
First Submitted That Met QC Criteria
November 8, 2016
First Posted (Estimate)
November 11, 2016
Study Record Updates
Last Update Posted (Actual)
March 21, 2019
Last Update Submitted That Met QC Criteria
March 19, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Disease
- Infant, Newborn, Diseases
- Bronchial Diseases
- Lung Diseases, Obstructive
- Lung Injury
- Infant, Premature, Diseases
- Bronchitis
- Syndrome
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Acute Lung Injury
- Bronchiolitis
Other Study ID Numbers
- 668259
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Distress Syndrome
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
University Hospital, Clermont-FerrandWithdrawn
-
China-Japan Friendship HospitalNot yet recruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress SyndromeFrance
-
Aqualung Therapeutics Corp.Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Unity Health TorontoRecruitingAcute Respiratory Distress Syndrome (ARDS)Canada, Spain, Italy, Brazil
-
Western University, CanadaEnrolling by invitationCOVID-19 Acute Respiratory Distress SyndromeCanada
-
Ain Shams UniversityCompletedCOVID-19 Acute Respiratory Distress SyndromeEgypt
-
Hospices Civils de LyonTerminatedAcute Respiratory Distress Syndrome (ARDS)France